Arca Biopharma | ABIO - PE Price to Earnings


Arca Biopharma reported 27.65 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Amgen 19.84 5.47 Mar/2026
Biogen 13.7 0.32 Mar/2026
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Capricor Therapeutics 2.76K 2.76K Dec/2022
Cipla 23.56 4.18 Mar/2026
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 4.06 75.75 Dec/2025
CSL 16.16 9.59 Dec/2025
Daiichi Sankyo 20.73 1.74 Dec/2025
Gilead Sciences 17.7 2.07 Mar/2026
GlaxoSmithKline 14.87 3.72 Mar/2026
Grifols 11.2 1.08 Dec/2025
Laboratory Of America 25.51 4.65 Mar/2026
Otsuka Holdings 14.31 2.24 Mar/2026
Pfizer 9.32 5.16 Mar/2026
United Therapeutics 20.42 3.1 Mar/2026